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The Gram-negative bacterium Vibrio vulniﬁcus is a common inhabitant of estuarine environments.
Globally, V. vulniﬁcus is a signiﬁcant foodborne pathogen capable of causing necrotizing wound infections
and primary septicemia, and is a leading cause of seafood-related mortality. Unfortunately, molecular
methods for the detection and enumeration of pathogenic V. vulniﬁcus are hampered by the genetically
diverse nature of this pathogen, the range of different biotypes capable of infecting humans and aquatic
animals, and the fact that V. vulniﬁcus contains pathogenic as well as non-pathogenic variants. Here we
report an alternative approach utilizing the development of a real-time PCR assay for the detection of
pathogenic V. vulniﬁcus strains based on a polymorphism in pilF, a gene previously indicated to be
associated with human pathogenicity. Compared to human serum reactivity, the real-time PCR assay
successfully detected pathogenic strains in 46 out of 47 analysed V. vulniﬁcus isolates (97.9%). The method
is also rapid, sensitive, and more importantly can be reliably utilised on biotype 2 and 3 strains, unlike
other current methods for V. vulniﬁcus virulence differentiation.
Crown Copyright  2011 Published by Elsevier Ltd. All rights reserved.1. Introduction
The Gram-negative halophilic bacterium Vibrio vulniﬁcus is
a natural inhabitant of tropical as well as temperate estuarine
environments. The species is present in high numbers in ﬁltering
organisms, such as oysters, especially in warmer months (Oliver,
2006). V. vulniﬁcus is a potent human pathogen, and is responsible
for more than 95% of all seafood-related deaths (Jones and Oliver,
2009). Isolated incidents of V. vulniﬁcus infections occur globally,
with cases frequently reported in the U.S.A., Europe and the Far East
(Dalsgaard et al., 1996; Chuang et al., 1992; Hlady and Klontz, 1996;
Baker-Austin et al., 2010a). Human infections typically occur after
ingestion of raw or undercooked shellﬁsh, particularly oysters, or
through entry via a ﬂesh wound (Oliver, 2005; Jones and Oliver,
2009). Signiﬁcantly, V. vulniﬁcus-associated primary septicemia
carries the highest fatality rate of any foodborne pathogen (Rippey,
1994). A review of 459 U.S. cases reported by the Food and Drug
Administration between 1992 and 2007 revealed that 51.6% of theax: þ44 0 1305 206601.
Baker-Austin).
011 Published by Elsevier Ltd. Allpatients infected with V. vulniﬁcus died (Jones and Oliver, 2009).
Most cases of infection (w95%) occur in males, who are immuno-
compromised or who have underlying diseases/syndromes which
result in elevated serum iron levels, primarily liver cirrhosis
secondary to alcohol abuse/alcoholism (Oliver and Kaper, 2001).
V. vulniﬁcus is currently subdivided into three biotypes based on
genetic, biochemical and serological features, as well as host range
(Bisharat et al., 1999; Tison et al., 1982). Biotype 1 strains are human
pathogens and are responsible for the vast majority of V. vulniﬁcus
infections reported worldwide. Biotype 2 contains strains which
cause disease and infections in aquatic animals such as eels and
occasionally in humans (Amaro and Biosca, 1996). A further biotype
(biotype 3) was discovered in 1996 after an outbreak of V. vulniﬁcus
infections in an Israeli ﬁsh market, and was later found to be
a hybrid of biotypes 1 and 2 (Bisharat et al., 2005). Not all strains of
V. vulniﬁcus appear to be able to cause disease in humans and
aquatic animals, and there is a need for the development of accu-
rate and rapid methods to distinguish virulent and avirulent
isolates. V. vulniﬁcus is phenotypically and serologically heteroge-
neous, has a wide host range encompassing different biotypes
capable of infecting humans and aquatic animals, and this
complexity has hampered efforts to provide a reliable assay torights reserved.
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have utilised different molecular markers in biotype 1 V. vulniﬁcus
as a proxy for potential human virulence, with varying degrees of
success. Differences in the sequence of the small subunit 16S rRNA
gene, as correlating with either clinical (pathogenic) and environ-
mental (non-pathogenic) origin have been utilised previously
(Aznar et al., 1994; Nilsson et al., 2003; Vickery et al., 2007).
V. vulniﬁcus biotype 1 strains have also been classiﬁed into two
genotypes based on a virulence-correlated gene, vcg (Rosche et al.,
2005). This genotype has been correlated with human infection for
90% of isolates from human cases having the vcgC sequence type
and 87% of environmental strains having the vcgE variant (Rosche
et al., 2005). Both 16S and vcg polymorphism can be used as
a predictive assay to distinguish pathogenic potential in biotype 1
V. vulniﬁcus strains, but have failed to adequately identify biotype 2
and biotype 3 strains, which are also potentially pathogenic to
humans (Sanjuan et al., 2009; Roig et al., 2010).
A recent report by Roig et al. (2010) demonstrated that a poly-
morphism in the pilus-type IV assembly protein of V. vulniﬁcus can
be utilised as a potential marker to distinguish pathogenic and non-
pathogenic V. vulniﬁcus strains, irrespective of biotype. The authors
found that V. vulniﬁcus strains appeared to be divided into two
groups in terms of sequence variability in the pilF gene, which
correlated strongly with potential pathogenicity (as ascertained by
human serum sensitivity). PilF is a protein required for pilus-type
IV assembly whose mutation in some bacterial pathogens results
in attenuated virulence in mice models (Chakraborty et al., 2008).
The high mortality rates coupled to the rapidity of V. vulniﬁcus
infections underlie the need for additional assays to detect and
enumerate these pathogens in a timely manner. The goal of the
current study was the development and evaluation of a real-time
PCR assay that would provide a rapid, sensitive and quantitative
method for the detection of V. vulniﬁcus strains encompassing the
entire genetic diversity of human pathogenic isolates. A further
objective of this work was the development of an assay that could
be used successfully on extracted DNA, boiled cells, as well as
directly in artiﬁcially spiked shellﬁsh matrices.
2. Materials and methods
2.1. Bacterial strains and growth conditions
V. vulniﬁcus strains, encompassing biotype 1, 2 and 3 isolates,
were grown at 28 C for 24 h in tryptone soy broth or on solid agar
media, supplemented with 5 g/liter NaCl. Strains wereFig. 1. Alignment of pilF gene sequences from a range of clinical and environmentallycryogenically stored at80 C prior to use, supplemented with 20%
(vol/vol) glyerol. A total of 69 bacterial strains, including
V. vulniﬁcus (n¼ 47), other Vibrio species (n¼ 13), and distantly
related reference strains (n¼ 9) were used to assess the speciﬁcity
of the oligonucleotide probe and primer sets used.
2.2. DNA isolation from individual strains
Late-logarithmically grown bacterial suspensions were pelleted
and DNA extracted using a Mini-prep protocol (Ausubel et al.,
2007). The quality and quantity of DNA was subsequently ascer-
tained spectrophotometrically using a NanoDrop ND1000 (Nano-
Drop Technologies, Wilmington, DE). Extracted DNA samples were
coded to conceal their identity, and a separate laboratory scientist
conducting the real-time PCR testing per strain was “blind” to the
original identiﬁer to minimize response measurement bias.
2.3. Sequence analysis and TaqMan probe design
The complete nucleotide sequences (open reading frame
regions only) for all full length pilF nucleotide sequences, deposited
by Roig et al. (2010), and encompassing GenBank accession
numbers FJ756476eFJ756489 and FJ899603eFJ899608, were
aligned using clustalW (Thompson et al., 1994). A region of the pilF
genes (approximate position 481e601) was analysed using primer
express software from DNASTAR (Madison, WI, USA). Initial
sequence alignment comparisons identiﬁed a variable region, at
approximate positions 534e571 in the pilF gene that demonstrated
signiﬁcant polymorphism for the design of an appropriate TaqMan
probe (Fig. 1), targeting a sequence speciﬁc to human serum-
resistant strains. The probe and primers were subsequently
assessed for species as well as strain speciﬁcity using a BLAST
search against publically available databases (Table 1).
2.4. Production of positive control material
To produce appropriate positive control material for the pilF
real-time PCR, the generation of cloned positive PCR was adopted.
Brieﬂy, for conventional PCR 50 ml per reaction mixes consisted of
30.65 ml molecular grade water, 10 ml 5 Green GoTaq Flexi Buffer
(Promega), 0.62 ml dNTP mixture (100 mM each); 1.2 ml of the pilF
primers (100 mM each, Table 1), 5 ml of MgCl2 (25 mM), 0.25 ml Taq
ﬂexi polymerase and 2.5 ml of extracted DNA samples. The
temperature proﬁle for this assay consisted of 3 min denaturation
at 94 C, followed by 30 cycles of 95 C for 45 s, 45 s at 55 C and-derived V. vulniﬁus isolates, indicating primer binding regions used in this study.
Table 1
Primers and probes used in this study.
Name Sequence (5’e3’) Reference
Pil F-F GATTGACTACGAYCCACACCG This study
Pil F-R GRCGCGCTTGGGTGTAG This study
PilF Probe (FAM)-TGCTCAACCTCGCTAAGTTGGAAATCGATAC-(TAMRA) This study
vvC-F MMAAACTCATTGARCAGTAACGAAA Baker-Austin et al. (2010b)
vvC-R AGCTGGATCTAAKCCCAATGC Baker-Austin et al. (2010b)
vcgC Probe (TAMRA)-AATTAAAGCCGTCAAGCCACTTGACTGTAAAGAA-(FAM) Baker-Austin et al. (2010b)
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Following PCR, amplicons were visualised by ethidium bromide
staining (0.5 mg/l) on 2.0% (wt/vol) agarose gels. Positive PCR
amplicons of predicted size were subsequently puriﬁed using
a Qiagen PCR puriﬁcation kit (Qiagen, Valencia, CA) following the
manufacturer’s recommendation and cloned into a TOPO TA
cloning kit (K4530-20, Invitrogen, Carlsbad, CA). Putative clones
were tested by PCR and positive transconjugants were subse-
quently plasmid extracted using a Qiagen mini-prep kit (Qiagen,
Valencia, CA). Plasmid DNA was subsequently serially diluted, and
standard weight/volume concentrations were converted to pilF
copies/microlitre concentrations by using the calculation: Copies
per microliter¼ grams per microliter/FW 6.02214151023,
where FW¼Amplicon Length (in Base Pairs) 660. Known
concentrations of pilF copies/microlitre were subsequently used for
quantiﬁcation purposes (Section 2.5).
2.5. TaqMan PCR assay
For real-time PCR experiments, the assay comprised of a total
reaction of 25 ml, consisting of 12.5 ml TaqMan Universal PCRMaster
Mix (Applied Biosystems), 0.45 ml each of forward and reverse
primer (as appropriate), V. vulniﬁcus pilF and vcgC primers
(100 nM), 5.6 ml nuclease-free water, and 1 ml of probe (500 nM,
Table 1). Five microliters of template (either chromosomal DNA,
plasmids, boiled cell lysate) was subsequently added, and each
reaction was performed in triplicate. Ampliﬁcation was performed
using an Applied Biosystems SDS 7900 real-time PCRmachine with
the following cycling parameters: 1 cycle at 95 C for 10 min fol-
lowed by 50 cycles at 95 C for 15 s and 60 C for 90 s. For each
assay, samples generating a positive reaction result (sigmoid-sha-
ped ampliﬁcation curve rising above the threshold) in any replicate
were considered positive. For each TaqMan sample replicate, a PCR
unit quantity (genome copies of cloned pilF per reaction) was
calculated using the slope of a standard curve of target DNA, with
a Cp value of 42.75 representing the theoretical limit of detection of
the assay equalling 1 genome copy of target per PCR reaction.
Standard curves for the determination of pilF DNA copy number
(per PCR reaction) were constructed using the average of duplicate
Cp values encompassing a concentration range of four serially
diluted clonedmaterial samples (typically from4 to8 dilution of
cloned material). Curves with r2 values of <0.99 were not used for
quantiﬁcation purposes. Analysed TaqMan sample replicates that
did not generate positive ampliﬁcation curves were omitted from
ﬁnal analyses, and the average from the three replicates was
calculated to give an overall quantity for that sample. To ascertain
potential PCR inhibition, a commercially available ampliﬁcation
control was utilised (TaqMan Exogenous internal positive control
reagents, Applied Biosystems), with minor modiﬁcations. Brieﬂy,
each sample of extracted shellﬁsh and extracted water (5 ml) were
analysed as above in triplicate, with the addition of 2.5 ml of 10
EXO IPC mix, 0.5 1 ml of 50 EXO IPC DNA, 12.5 ml TaqMan Universal
PCR Master Mix (Applied Biosystems), and 4.5 ml of nuclease-free
water. Inhibition in this context was deﬁned by the absence of
target ampliﬁcation.2.6. Shellﬁsh bioaccumulation and DNA extraction procedures
For shellﬁsh bioaccumulation experiments, four 50 litre capacity
tanks (3 experimental and 1 control) were ﬁlled with 22 l (0. 5 l)
sterile seawater and maintained at 15 C (1 C) with constant air
sparging. Twenty-ﬁve un-depurated live Paciﬁc oysters (Crassostrea
gigas) were obtained from a local wholesaler (Weymouth, UK),
evenly distributed into each tank and left for 24 h to acclimatise,
prior to the addition of bacterial amendments. For bioaccumulation
experiments, V. vulniﬁcus strain E12 (a strain previously identiﬁed
pilF positive by real-time PCR, Table 2) was grown up overnight in
alkaline saline peptone water ASPW (Oxoid, Basingstoke, United
Kingdom), and added to the test tank. The required quantities of
bacterial amendments were assessed by analysing the cell cultures
spectrophotometrically, and by adjusting the concentration of
strain E12 in appropriate volumes of sterile ASPW prior to use. A
spiking volume of strain E12 (optical density of 1) corresponding to
approximately 109 cells was added to the test tank and mixed. Ten
C. gigas were removed after 6 h of exposure, and opened. For each
sample, the digestive glands (stomach and digestive diverticula)
were removed from each animal and weighed. The digestive glands
were subsequently pooled together, and then ﬁnely chopped using
a sterile razor blade. Homogenates were then prepared by treating
the chopped digestive glands with 100 mg/ml Proteinase K solution
(30 U/mg; Promega) as previously described (Jothikumar et al.,
2005; Baker-Austin et al., 2010b). Homogenates were stored at
4 C prior to testing. For each shellﬁsh sample, 500 ml of homoge-
nate was processed using the NucliSens magnetic extraction kit
(BioMerieux, Lyon, France) essentially following themanufacturer’s
instructions. Extracted samples (ﬁnal volume 100 ml) were subse-
quently used directly in real-time PCR experiments.
3. Results and discussion
To date, no single molecular approach has been developed that
can determine potential human pathogenicity in V. vulniﬁcus
strains with 100% accuracy and conﬁdence, although recent studies
have demonstrated the utility of combining several molecular
virulence testing approaches simultaneously (Han and Ge, 2010). In
this regard, we believe that pilF is a useful and reliable additional
target for epidemiological and diagnostic tests alongside other re-
ported assays for virulence testing in V. vulniﬁcus, such as 16S rRNA
(Aznar et al., 1994; Nilsson et al., 2003; Vickery et al., 2007),
capsular polysaccharide genes (Han et al., 2009), and vcgC and vcgE
analysis (Rosche et al., 2005; Baker-Austin et al., 2010b;Warner and
Oliver, 2008).
Initial experiments using a cloned pilF fragment from strain E12,
a previously identiﬁed pathogenic and vcgCþ V. vulniﬁcus isolate,
showed excellent linear agreement (r2 0.999) between the ex-
pected standard curve and detection of the pilF target (Fig. 2, inset
B). Subsequent analysis of DNA diluted over 10 orders of magnitude
was capable of reliably identifying this target using real-time PCR.
Repeated analysis of highly diluted cloned material indicated that
the observed limits of detection correspond to less than 5 copies of
pilF per reaction, demonstrating optimum reaction kinetics of the
Table 2
Bacterial strains analysed in this study.
Strain Isolation/origin vcgC RT-PCR pilF RT-PCR Human
serum resistancea
Vibrio vulniﬁcus biotype 1 strains
ATCC 33816 Human blood (USA) þ þ þ
E12 Oyster (USA) þ þ þ
CECT 5168 Human blood (USA) þ þ þ
CECT 529 Human blood (USA)   
V4 Human blood (Australia) þ þ þ
N87 Human blood (Japan) þ þ þ
KH03 Human blood (Japan) þ þ þ
YJ106 Human blood (Taiwan) þ þ þ
CECT 4867 Diseased eel (Sweden)   
PD-1 Eel tank water (Spain)   
L49 Brackish water (Japan)   
Riu1 Seawater (Spain)  þ 
CECT 4608 Eel farm water (Spain)  þ þ
CG100 Oyster (Taiwan) þ þ þ
CS9133 Human blood (South Korea) þ þ þ
CG106 Oyster (Taiwan) þ þ þ
CECT 4606 Eel (Spain)   
Vibrio vulniﬁcus biotype 2 strains
CECT 5198 Diseased eel (Spain)   
A13 Diseased eel (Spain)   
CECT 5769 Diseased eel (Spain)   
A11 Diseased eel (Spain)   
A14 Diseased eel (Spain)   
21A Diseased eel (Denmark)  b 
22 Diseased eel (Denmark)   
27 Diseased eel (Denmark)   
CECT 4862 Diseased eel (Japan)  þ þ
CECT 4604 Diseased eel (Spain) þ þ þ
CECT 4999 Diseased eel (Spain)  þ þ
CECT 5763 Eel tank water (Spain)  þ þ
CIP8190 Human blood (France)  þ þ
CECT 4866 Human blood (Australia)  þ þ
CECT 5762 Healthy eel (Spain)  þ þ
Riu-2 Seawater (Spain)  þ þ
CECT 4868 Diseased eel (Norway)  þ þ
90-2-11 Diseased eel (Denmark)  þ þ
94-8-112 Human wound (Denmark)  þ þ
94-9-123 Seawater (Denmark)  þ þ
CECT 4865 Diseased shrimp (Taiwan)  þ þ
UE516 Diseased eel (Taiwan)  þ þ
CECT 897 Diseased eel (Japan)  þ þ
95-8-162 Diseased eel (Denmark)  þ þ
95-8-6 Diseased eel (Denmark)  b 
Vibrio vulniﬁcus biotype 3 strains (Serovar O)
11028 Human disease (Israel)  þ þ
162 Human disease (Israel)  þ þ
12 Human disease (Israel)  þ þ
32 Human disease (Israel)  þ þ
97 Human disease (Israel)  þ þ
Other Vibrio spp.
V. ﬂuvialis VF10 Type strain NCTC 11327   NA
V. cholerae VC9 Type strain NCTC 80442   NA
V. alginolyticus 05/073   NA
V. cholerae V05/086   NA
V. ﬂuvialis Type strain NCTC 11327   NA
V. parahaemolyticus V05/070   NA
V. parahaemolyticus V05/086   NA
V .parahaemolyticus Type strain NCTC 10885   NA
V. parahaemolyticus V05/062   NA
V. furnissi V06/003   NA
V. cincinnatiensis V06/001   NA
V. metschinovii V06/004   NA
V. mimicus V06/300   NA
Other bacteria
S. paucimobilis SP21 Type strain NCTC 11030   NA
S. nottingham Type strain NCTC 7832   NA
R. planticola Type strain NCTC 9528   NA
P. aeruginosa PA20 Type strain NCTC 10332   NA
P. mirabilis PM22 Type strain NCTC 10975   NA
E .coli E012 Type strain NCTC 12241   NA
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Table 2 (continued )
Strain Isolation/origin vcgC RT-PCR pilF RT-PCR Human
serum resistancea
E .coli ECL13 Type strain NCTC 13216   NA
K. aerogenes KA23 Type strain NCTC 9528   NA
E. faecalis EF9 Type strain NCTC 775   NA
NA, not assessed.
a Previously determined by Roig et al. (2010).
b Showed weak non-sigmoidal ampliﬁcation of pilF.
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assay was evaluated by testing pathogenic and non-pathogenic
V. vulniﬁcus strains (deemed pathogenic to humans based on
previous human serum reactivity analysis), as well as a range of
closely and distantly related bacteria. To compare pilF with estab-
lished pathogenicity analysis we analysed strains using vcgC real-
time PCR, an assay previously shown to successfully identify
pathogenic biotype 1 V. vulniﬁcus isolates (Baker-Austin et al.,
2010b). In agreement with previous work (Roig et al., 2010), the
results here demonstrated that the pilF was capable of correctly
identifying the vast majority of human serum-resistant strains,
irrespective of biotype (Table 2). Of the 17 biotype 1 V. vulniﬁcus
strains analysed for pilF and vcgC, 16 strains were correctly identi-
ﬁed by both assays (94.1%). Of the 25 biotype 2 strains analysed,
only 9 strains were correctly identiﬁed using vcgC real-time PCR,
compared to 25 using pilF (36% and 100% identiﬁcations, respec-
tively). All ﬁve biotype three strains were correctly identiﬁed using
pilF (100%), whilst no positive results were detected by vcgC (0%),
Table 2. No ampliﬁcation of closely related vibrio or non-vibrio
strains were observed, indicating the speciﬁcity of the pilF real-
time PCR assay (Table 2). The pilF assay thus contrasts with other
targets used to identify pathogenic strains of V. vulniﬁcus, such as
16S rRNA (Aznar et al., 1994; Nilsson et al., 2003; Vickery et al.,
2007) and vcgC polymorphisms (Rosche et al., 2005; Warner and
Oliver, 2008; Baker-Austin et al., 2010b), which have shown
limited usefulness in detecting biotype 2 and biotype 3 V. vulniﬁcus
strains potentially dangerous to human health (Roig et al., 2010;
Sanjuan et al., 2009). Both biotype 2 (serovar E and serovar I) and
biotype 3 V. vulniﬁcus strains represent important human patho-
gens (Amaro and Biosca, 1996; Bisharat et al., 1999), and the ability
to identify potentially virulent strains rapidly is of paramountFig. 2. Example of real-time PCR curves generated by a serial dilution range of clonedmateriaimportance. We found that a small number of non-pathogenic
V. vulniﬁcus strains (i.e. isolates possessing no serum resistance)
did demonstrate weak ampliﬁcation when analysed with the pilF
real-time PCR assay (Table 2). However, these strains did not show
true sigmoidal ampliﬁcation curves, which were evident in all
analysed human serum resistant V. vulniﬁcus strains (data not
shown). The non-speciﬁc ampliﬁcations are probably caused by the
relatively close sequence homology of the two major poly-
morphisms in the pilF gene, whereby some co-ampliﬁcation of non-
pathogenic pilF DNA from non-pathogenic strains is difﬁcult to
eliminate. We found that reducing the number of thermal cycles,
increasing the cycle threshold and iterative analysis of all ampliﬁ-
cations during the real-time PCR assay successfully eliminated
these false-positive results. Irrespective, several strains producing
discordant results are currently subject to in-depth characteriza-
tion including additional human serum analysis and genomic
sequencing to glean additional insights into the pathogenic
potential of these isolates.
Real-time PCR demonstrated a strong dynamic range of detec-
tion, with samples reliably detected from cloned plasmid template
diluted to over 9 orders of magnitude in serial dilution experiments
(Fig. 2), corresponding to single number copies of pilF per PCR
reaction. Real-time PCR assays were performed on DNA extracted
from bioaccumulated shellﬁsh samples (Fig. 3). We were able to
identify pilF directly from shellﬁsh matrices (Paciﬁc oyster, average
Ct value 28.99, Fig. 3), whereas no signal was evident from negative
control samples (no vibrio amendment), or from extracted water.
No matrix (shellﬁsh tissue) inhibition was observed during these
experiments. The results from artiﬁcially bioaccumulated samples
(Fig. 3) correspond to detection of approximately 7600 genome
copies of pilF per reaction based on cloned pilF target DNA (Sectionl (A) and corresponding standard curves for V. vulniﬁcus as detected by real-time PCR (B).
Fig. 3. Detection of pilF in artiﬁcially amended shellﬁsh matrices.
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purposes in shellﬁsh matrices. These results mirror prior ﬁndings
(Baker-Austin et al., 2010b) which demonstrated that the nucleic
acid extraction procedure detailed here can be used to directly
extract bacterial nucleic acids from shellﬁsh matrices, without the
need for prior enrichment of samples. Given the promising sensi-
tivity of this assay, the ability to identify pathogenic V. vulniﬁcus
from naturally contaminated rather than artiﬁcially spiked samples
is an area that will be further investigated in future work.
In conclusion, this real-time PCR assay represents a rapid means
of distinguishing V. vulniﬁcus strains potentially harmful to human
health, irrespective of biotype. The assay was applied to single
cultures, extracted DNA and to artiﬁcially bioaccumulated shellﬁsh
samples, and is an especially useful target to detect potentially
pathogenic biotype 2 and 3 strains of human health relevance. This
tool will enable early detection capability in a range of different
applications, such as food processing, regulatory and clinical
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